Making Sense of Multiple Organ Dysfunction Syndrome

Critical Care Nursing Clinics of North America

Volumn 19, Issue 1, 2007, Pages 87-97

  Krau, Stephen D ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; HUMAN; INTENSIVE CARE; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

CRITICAL CARE; HUMANS; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; OXYGEN CONSUMPTION; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33847360603     PISSN: 08995885     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccell.2006.11.002     Document Type: Review

References (53)

1. Beal A.L., and Cerr F.B. Multiple organ failure syndrome in the 1990s: systemic inflammatory response and organ dysfunction. JAMA 271 3 (1994) 226-233
2. Faist E., Baue A.E., Dittmer H., et al. Multiple organ failure in polytrauma patients. J Trauma 118 (1983) 243-249
3. Pine R.W., Wertz M.J., Lennard E.S., et al. Determinants of organ malfunction or death in patients with intra-abdrominal sepsis: a discriminant analysis. Arch Surg 118 (1983) 243-249
4. Schmidt H., Muller-Werden U., Hoffman T., et al. Autonomic dysfunction predicts mortality in patient with multiple organ dysfunction syndrome in different age groups. Crit Care Med 3 9 (2005) 1994-2002
5. Lydon A., and Jeevendra-Martin J.A. Apoptosis in critical illness. Int Anesthesiol Clin 41 1 (2003) 65-77
6. Vollman T.J., Hendricks T., and Gors R.A. Zymosan-induced generalized inflammation: experimental studies into mechanisms leading to multiple organ dysfrunction syndrome. Shock 23 4 (2005) 291-297
7. Marshall J.C. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29 (2001) S99-S106
8. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
9. Walsh C.R. Multiple organ dysfunction syndrome after multiple trauma. Orthop Nurs 24 5 (2005) 324-333
10. Walsh C.R. Multiple organ dysfunction syndrome. In: Melander S.D. (Ed). Case studies in critical care nursing: a guide for application and review. 3rd edition (2004), W.B. Saunders, Philadelphia 352-369
11. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864-870
12. Baldwin K.M., and Morris S.D. Shock, multiple organ dysfunction syndrome, and burns in adults and children. In: McCance K.L., and Huether S.E. (Eds). Pathophysiology: the biological basis for disease in adults and children. 4th edition (2002), W.B. Saunders, Philadelphia 1483-1512
13. Tantalean J.A., Leon R.J., Santos A.A., et al. Multiple organ dysfunction syndrome in children. Pediatr Crit Care Med 4 2 (2003) 181-185
14. Levy M., Fink M., Marshall J., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conditions. Crit Care Med 31 4 (2003) 1250-1256
15. Offner P.J., and Moore E.E. Risk factors for MOF and pattern of organ failure following severe trauma. In: Baue A.E., Eugen F., and Fry D.E. (Eds). Mutiple organ failure: pathophysiology, prevention, and therapy (2000), Springer, New York 30-43
16. Fry D.E. Systemic inflammation response and multiple organ dysfunction syndrome: biologic domino effect. In: Baue A.E., Eugen F., and Fry D.E. (Eds). Mutiple organ failure: pathophysiology, prevention, and therapy (2000), Springer, New York 23-39
17. Marshall J., and Sweeney D. Microbial infection and the septic response in critical surgical illness. Arch Surg 125 (1990) 17-23
18. Hoyer D., Friedrich H., Zweiner U., et al. Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients. Int J Cardiol 108 (2006) 356-369
19. Moerer O., Schmid A., Hoffman M., et al. Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 28 10 (2002) 1440-1446
20. Danner R.L., Elin R.J., Hosseini J.M., et al. Endotoxemia in human septic shock. Chest 99 (1991) 169-175
21. Murphy D.B., Cregg N., Tremblay L., et al. Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 162 (2000) 27-33
22. Workman M.L. Concepts of inflammation and the immune response. In: Ignatavicius D.D., and Workman M.L. (Eds). Medical-surgical nursing: critical thinking for collaborative care. 5th edition (2006), Elsevier, St. Louis (MO) 360-379
23. Vincent J.L. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care 5 Suppl 2 (2001) S1-S5
24. Leithauser B., Matthias F.R., Nicolai U., et al. Hemostaticss abnormalities and the severity of illness in patients at the onset of clinically defined sepsis: possible indication of the degree of endothelial cell activation?. Intensive Care Med 22 (1996) 631-636
25. Boldt J., Papsdorf M., Rothe A., et al. Changes of the hemostatic network in in critically ill patients: is there a difference between sepsis, trauma, and neurosurgery patients?. Crit Care Med 28 (2000) 445-450
26. Dubin A., Murias G., Maskin B., et al. Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study. Crit Care 9 2 (2005) R66-R73
27. Knotzer H., Pajk W., Dunser M.W., et al. Regional microvascular function and vascular reactivity in patients with different degrees of multiple organ dysfunction syndrome. Anesth Analg 102 4 (2006) 1187-1193
28. Papathanassoglou E., Moynihan J., and Ackerman M. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 28 (2000) 537-549
29. Deitch E.A., Xu D., and Kaise V.L. Role of the gut in the development of injury- and shock induced SIRS and MODS: the gut-lymph hypothesis, a review. Front Biosci 11 (2006) 520-528
30. Magnotti Louis J., and Deitch Edwin A. Burns, bacterial translocation, gut barrier function and failure. J Burn Care Rehabil 26 5 (2005) 383-391
31. Duhon J.L. When organs fail one by one. RN 69 5 (2006) 44-47
32. Secor V.H. Multiple organ dysfunction syndrome: background, etiology, and sequence of events. In: Secor V.H. (Ed). Multiple organ dysfunction & failure: pathophysiology and clinical complications. 2nd edition (1996), Mosby, St. Louis (MO) 3-18
33. Kleinpell R. Advances in treating patients with severe sepsis: role of drotrecogin alfa (activated). Crit Care Nurse 3 3 (2003) 16-24
34. Kaplan L. Systemic inflammatory response syndrome. 2004. Available at: http://www.emedicine.com/med/topic3372.htm. Accessed October 10, 2006.
35. Kleinpell R.M. Multisystem problems. In: Chulay M., and Burns S.M. (Eds). AACN essentials of critical care nursing (2006), McGraw-Hill, New York 267-278
36. Bhatia M., and Moochhala S. Role of inflammatory mediators in pathophysiology of acute respiratory distress syndrome. J Pathol 202 2 (2004) 145-156
37. Schmidt H., Muller-Werden U., Nuding S., et al. Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome-the potential role of disease severity. Intensive Care Med 30 (2004) 665-672
38. Phillips RA. Stopping the train wreck of SIRS. Nursing Made Incredibly Easy. 2006; July/August: 44-54.
39. Secor V.H. Multiple organ dysfunction syndrome: overview and conclusions. In: Secor V.H. (Ed). Multiple organ dysfunction & failure: pathophysiology and clinical complications. 2nd edition (1996), Mosby, St. Louis (MO) 402-423
40. Rauen C.A., and Stamatos C.A. Caring for geriatric patients with MODS. Am J Nurs 97 5 (1997) 16BB-16HH
41. Nicholson D.P. Review of corticosteroid treatment in sepsis and septic shock: pro or con. Crit Care Clin 5 (1989) 151-155
42. Bernard G.R., et al. High-dose corticosteroids in patients with adult respiratory distress syndrome. N Engl J Med 317 (1987) 1565-1570
43. Boone R.C., Fisher Jr. C.J., Clemmer T.P., et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 (1987) 653-658
44. Hartung T., von Aulock S., and Albrecht W. Growth factors G-CSF and GM-CSF: clinical options. In: Baue A.E., Faist E., and Fry D.E. (Eds). Multiple organ failure: pathophysiology, prevention, and therapy (2000), Springer-Verlag, New York 621-629
45. Manns B.J., Lee H., Doig C.J., et al. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 347 (2002) 993-1000
46. Peck P (2004). Early initiation of drotrecogin alpha may improve survival. Medscape Medical News. Available at: http://www.medscape.com/viewarticle/470592. Accessed September, 2006.
47. Cibrian D., Ajamieh H., Berlanga J., et al. Use of growth-hormone-releasing peptide-6 (GHRP-6) for the prevention of multiple organ failure. Clin Sci 110 (2006) 563-573
48. Shoemaker W.C., Appel P.L., Kram H.B., et al. Hemodynamic and oxygen transport monitoring to titrate therapy in septic shock. New Horiz 1 (1993) 145-159
49. Deitch E.A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 125 (1990) 403-404
50. Alexander J.W. Immunoenhancement via enteral nutrition. Arch Surg 128 (1993) 1242-1245
51. Rivers E., Nguyen B., Havstad S., et al. Early goal directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
52. Pontet J., Contreras P., Curbelo J., et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care 18 3 (2003) 156-163
53. Langemo D.K., and Brown G. Skin fails too: acute, chronic and end-stage skin failure. Adv Wound Care 19 4 (2006) 206-211